Consensus Statement on Palliative Lung Radiotherapy: Third International Consensus Workshop on Palliative Radiotherapy and Symptom Control

被引:26
作者
Rodrigues, George [1 ]
Macbeth, Fergus [2 ]
Burmeister, Bryan [3 ]
Kelly, Karie-Lynn [4 ]
Bezjak, Andrea [5 ]
Langer, Corey [6 ]
Hahn, Carol [7 ]
Movsas, Benjamin [8 ]
机构
[1] Univ Western Ontario, Dept Radiat Oncol, London, ON, Canada
[2] Natl Inst Hlth & Clin Excellence, London, England
[3] Princess Alexandra Hosp, Dept Radiat Oncol, Woolloongabba, Qld 4102, Australia
[4] Kootenai Canc Ctr, Dept Radiat Oncol, Coeur Dalene, ID USA
[5] Princess Margaret Hosp, Dept Radiat Med, Toronto, ON M4X 1K9, Canada
[6] Univ Penn, Dept Med, Philadelphia, PA 19104 USA
[7] Duke Radiat Oncol, Raleigh, NC USA
[8] Henry Ford Hosp, Dept Radiat Oncol, Detroit, MI 48202 USA
关键词
Concurrent chemotherapy; Consensus statement; Endobronchial brachytherapy; External-beam radiation therapy; Lung cancer; NONSMALL CELL LUNG; QUALITY-OF-LIFE; PHASE-I; ENDOBRONCHIAL BRACHYTHERAPY; THORACIC RADIOTHERAPY; RADIATION-THERAPY; RANDOMIZED-TRIAL; CANCER; FRACTIONATION; IRRADIATION;
D O I
10.1016/j.cllc.2011.04.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The purpose of this work is to disseminate a consensus statement on palliative radiotherapy (RT) of lung cancer created in conjunction with the Third International Lung Cancer Consensus Workshop. The palliative lung RT workshop committee agreed on 5 questions relating to (1) patient selection, (2) thoracic external-beam radiation therapy (XRT) fractionation, (3) endobronchial brachytherapy (EBB), (4) concurrent chemotherapy (CC), and (5) palliative endpoint definitions. A PubMed search for primary/cross-referenced practice guidelines, consensus statements, meta-analyses, and/or systematic reviews was conducted. Final consensus statements were created after review and discussion of the available evidence. The following summary statements reflect the consensus of the international working group. 1. Key factors involved in the decision to deliver palliative RT include performance status, tumor stage, pulmonary function, XRT volume, symptomatology, weight loss, and patient preference. 2. Palliative thoracic XRT is generally indicated for patients with stage IV disease with current/impending symptoms and for patients with stage III disease treated for palliative intent. 3. There is no evidence to routinely recommend EBB alone or in conjunction with other palliative maneuvers in the initial palliative management of endobronchial obstruction resulting from lung cancer. 4. There is currently no evidence to routinely recommend CC with palliative-intent RT. 5. Standard assessment of symptoms and health-related quality of life (QOL) using validated questionnaires should be carried out in palliative RT lung cancer trials. Despite an expanding literature, continued prospective randomized investigations to better define the role of XRT, EBB, and CC in the context of thoracic palliation of patients with lung cancer is needed.
引用
收藏
页码:1 / 5
页数:5
相关论文
共 50 条
  • [31] Management of unresected stage III non-small cell lung cancer: A systematic review
    Okawara, Gordon
    Mackay, Jean A.
    Evans, William K.
    Ung, Yee C.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (04) : 377 - 393
  • [32] Rees G J, 1997, Clin Oncol (R Coll Radiol), V9, P90, DOI 10.1016/S0936-6555(05)80446-7
  • [33] Reinfuss M, 1999, Cancer Radiother, V3, P475, DOI 10.1016/S1278-3218(00)88254-2
  • [34] Salvo N, 2009, CURR ONCOL, V16, P100
  • [35] Dose escalation of docetaxel concomitant with hypofractionated, once weekly chest radiotherapy for non-small-cell lung cancer - A phase I study
    Schwarzenberger, P
    Theodossiou, C
    Barron, S
    Diethelm, L
    Boyle, M
    Harrison, L
    Wynn, RB
    Salazar, OM
    Fariss, A
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2004, 27 (04): : 395 - 399
  • [36] A phase I study of pernetrexed, carboplatin, and concurrent radiotherapy in patients with locally advanced or metastatic non-small cell lung or esophageal cancer
    Seiwert, Tanguy Y.
    Connel, Philip P.
    Mauer, Ann M.
    Hoffman, Philip C.
    George, Christopher M.
    Szeto, Livia
    Salgia, Ravi
    Posther, Katherine E.
    Nguyen, Binh
    Haraf, Daniel J.
    Vokes, Everett E.
    [J]. CLINICAL CANCER RESEARCH, 2007, 13 (02) : 515 - 522
  • [37] A prospective, randomised study to compare two palliative radiotherapy schedules for non-small-cell lung cancer (NSCLC)
    Senkus-Konefka, E
    Dziadziuszko, R
    Bednaruk-Mlynski, E
    Pliszka, A
    Kubrak, J
    Lewandowska, A
    Malachowski, K
    Wierzchowski, M
    Matecka-Nowak, M
    Jassem, J
    [J]. BRITISH JOURNAL OF CANCER, 2005, 92 (06) : 1038 - 1045
  • [38] PALLIATIVE RADIOTHERAPY FOR INOPERABLE CARCINOMA OF THE LUNG - FINAL REPORT OF A RTOG MULTI-INSTITUTIONAL TRIAL
    SIMPSON, JR
    FRANCIS, ME
    PEREZTAMAYO, R
    MARKS, RD
    RAO, DV
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1985, 11 (04): : 751 - 758
  • [39] Somerfield MR, 1997, J CLIN ONCOL, V15, P2996
  • [40] Defining and analysing symptom palliation in cancer clinical trials: a deceptively difficult exercise
    Stephens, RJ
    Hopwood, P
    Girling, DJ
    [J]. BRITISH JOURNAL OF CANCER, 1999, 79 (3-4) : 538 - 544